News

European Medicines Agency recommends approval of Mekinist for the treatment of melanoma

First MEK inhibitor to receive a positive opinion in the EU for the treatment of adult patients with unresectable or metastatic melanoma.

28th April 2014

For more information or an estimate, contact us »

Who we help: